Loraz and Lupus nephritis - a phase IV clinical study of FDA data

Summary:

Lupus nephritis is reported as a side effect among people who take Loraz (lorazepam), especially for people who are male, 30-39 old, also take Amlodipine, and have High blood pressure.

The phase IV clinical study analyzes which people have Lupus nephritis when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.

What is Lupus nephritis?

Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue) is found to be associated with 164 drugs and 372 conditions by eHealthMe. Check the latest studies of Lupus nephritis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

161,700 people reported to have side effects when taking Loraz.
Among them, 12 people (0.01%) have Lupus nephritis.

Among these 12 people:

What is the gender of people who have Lupus nephritis when taking Loraz? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Lupus nephritis when taking Loraz? *

What are other drugs people take besides Loraz? *

What are other side effects people have besides Lupus nephritis? *

Weight Decreased: 5 people, 41.67%
High Blood Cholesterol: 5 people, 41.67%
Nausea And Vomiting: 5 people, 41.67%
Nausea (feeling of having an urge to vomit): 5 people, 41.67%
Memory Loss: 5 people, 41.67%
Indigestion: 5 people, 41.67%
Diarrhea: 5 people, 41.67%
High Blood Pressure: 5 people, 41.67%
Chest Pain: 5 people, 41.67%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 5 people, 41.67%

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 75.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 41.67%
Psychotic Disorder: 5 people, 41.67%
Urinary Tract Inflammation: 4 people, 33.33%
Throat Irritation: 4 people, 33.33%
Angiopathy (generic term for a disease of the blood vessels): 4 people, 33.33%
Aura: 4 people, 33.33%
Chest Pain: 4 people, 33.33%
Gastric Ph Decreased: 4 people, 33.33%
Gastric Ulcer (stomach ulcer): 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and have Lupus nephritis?

- Check whether Lupus nephritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loraz:

Loraz (165,695 reports)

Lupus nephritis treatments and more:

Lupus nephritis (10,611 reports)

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lupus nephritis:

Lupus nephritis (164 drugs)

Browse all the conditions that are associated with Lupus nephritis:

Lupus nephritis (372 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.